243 related articles for article (PubMed ID: 11311056)
21. Structure-based design of a new bisintercalating anthracycline antibiotic.
Chaires JB; Leng F; Przewloka T; Fokt I; Ling YH; Perez-Soler R; Priebe W
J Med Chem; 1997 Jan; 40(3):261-6. PubMed ID: 9022792
[TBL] [Abstract][Full Text] [Related]
22. Monitoring of the internalization of neuropeptide Y on neuroblastoma cell line SK-N-MC.
Fabry M; Langer M; Rothen-Rutishauser B; Wunderli-Allenspach H; Höcker H; Beck-Sickinger AG
Eur J Biochem; 2000 Sep; 267(17):5631-7. PubMed ID: 10951224
[TBL] [Abstract][Full Text] [Related]
23. Poly(2-ethyl-2-oxazoline)-doxorubicin conjugate-based dual endosomal pH-sensitive micelles with enhanced antitumor efficacy.
Li J; Zhou Y; Li C; Wang D; Gao Y; Zhang C; Zhao L; Li Y; Liu Y; Li X
Bioconjug Chem; 2015 Jan; 26(1):110-9. PubMed ID: 25506713
[TBL] [Abstract][Full Text] [Related]
24. Anthracycline-GnRH derivative bioconjugates with different linkages: synthesis, in vitro drug release and cytostatic effect.
Schlage P; Mezo G; Orbán E; Bosze S; Manea M
J Control Release; 2011 Dec; 156(2):170-8. PubMed ID: 21864594
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and antitumor activity of 7-O-[2,6-dideoxy-2-fluoro-5-C-(trifluoromethyl)-alpha-L-talopyranosyl]- daunomycinone and -adriamycinone.
Nakai K; Takagi Y; Tsuchiya T
Carbohydr Res; 1999 Mar; 316(1-4):47-57. PubMed ID: 10420587
[TBL] [Abstract][Full Text] [Related]
26. New daunomycin-oligoarginine conjugates: synthesis, characterization, and effect on human leukemia and human hepatoma cells.
Miklán Z; Orbán E; Csík G; Schlosser G; Magyar A; Hudecz F
Biopolymers; 2009; 92(6):489-501. PubMed ID: 19521976
[TBL] [Abstract][Full Text] [Related]
27. Transferrin conjugates of doxorubicin: synthesis, characterization, cellular uptake, and in vitro efficacy.
Kratz F; Beyer U; Roth T; Tarasova N; Collery P; Lechenault F; Cazabat A; Schumacher P; Unger C; Falken U
J Pharm Sci; 1998 Mar; 87(3):338-46. PubMed ID: 9523988
[TBL] [Abstract][Full Text] [Related]
28. A new daunomycin-peptide conjugate: synthesis, characterization and the effect on the protein expression profile of HL-60 cells in vitro.
Orbán E; Manea M; Marquadt A; Bánóczi Z; Csík G; Fellinger E; Bosze S; Hudecz F
Bioconjug Chem; 2011 Oct; 22(10):2154-65. PubMed ID: 21950465
[TBL] [Abstract][Full Text] [Related]
29. Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance.
Fang L; Zhang G; Li C; Zheng X; Zhu L; Xiao JJ; Szakacs G; Nadas J; Chan KK; Wang PG; Sun D
J Med Chem; 2006 Feb; 49(3):932-41. PubMed ID: 16451059
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of daunorubicin analogues containing truncated aromatic cores and unnatural monosaccharide residues.
Fan E; Shi W; Lowary TL
J Org Chem; 2007 Apr; 72(8):2917-28. PubMed ID: 17373847
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological evaluation of novel daunorubicin-estrogen conjugates.
Kasiotis KM; Magiatis P; Pratsinis H; Skaltsounis A; Abadji V; Charalambous A; Moutsatsou P; Haroutounian SA
Steroids; 2001 Oct; 66(10):785-91. PubMed ID: 11522342
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, cytocidal activity and estrogen receptor α affinity of doxorubicin conjugates at 16α-position of estrogen for site-specific treatment of estrogen receptor positive breast cancer.
Saha P; Fortin S; Leblanc V; Parent S; Asselin É; Bérubé G
Steroids; 2012 Sep; 77(11):1113-22. PubMed ID: 22801351
[TBL] [Abstract][Full Text] [Related]
33. 3'-Deamino-4'-epi-3'-hydroxy-daunorubicin and -doxorubicin. Synthesis and antitumor activity.
Horton D; Priebe W; Varela O
J Antibiot (Tokyo); 1984 Dec; 37(12):1635-41. PubMed ID: 6549317
[TBL] [Abstract][Full Text] [Related]
34. Binding and cytotoxicity of HPMA copolymer conjugates to lymphocytes mediated by receptor-binding epitopes.
Tang A; Kopeiková P; Kopeckevá J
Pharm Res; 2003 Mar; 20(3):360-7. PubMed ID: 12669954
[TBL] [Abstract][Full Text] [Related]
35. The mechanism for anthracycline-induced inhibition of collagen biosynthesis.
Muszyńska A; Wolczyński S; Pałka J
Eur J Pharmacol; 2001 Jan; 411(1-2):17-25. PubMed ID: 11137854
[TBL] [Abstract][Full Text] [Related]
36. 99mTc-labeled neuropeptide Y analogues as potential tumor imaging agents.
Langer M; La Bella R; Garcia-Garayoa E; Beck-Sickinger AG
Bioconjug Chem; 2001; 12(6):1028-34. PubMed ID: 11716696
[TBL] [Abstract][Full Text] [Related]
37. Improved In Vivo Anti-Tumor and Anti-Metastatic Effect of GnRH-III-Daunorubicin Analogs on Colorectal and Breast Carcinoma Bearing Mice.
Ranđelović I; Schuster S; Kapuvári B; Fossati G; Steinkühler C; Mező G; Tóvári J
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31557968
[TBL] [Abstract][Full Text] [Related]
38. Novel cleavable cell-penetrating peptide-drug conjugates: synthesis and characterization.
Lelle M; Frick SU; Steinbrink K; Peneva K
J Pept Sci; 2014 May; 20(5):323-33. PubMed ID: 24677287
[TBL] [Abstract][Full Text] [Related]
39. A novel cyclic analog of neuropeptide Y specific for the Y2 receptor.
Beck-Sickinger AG; Grouzmann E; Hoffmann E; Gaida W; van Meir EG; Waeber B; Jung G
Eur J Biochem; 1992 Jun; 206(3):957-64. PubMed ID: 1318842
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and antitumor activity of 4'-O-methyldaunorubicin, 4'-O-methyladriamycin, and their 4'-epi analogues.
Cassinelli G; Ruggieri D; Arcamone F
J Med Chem; 1979 Feb; 22(2):121-3. PubMed ID: 423191
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
